Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound, also known as (5S)-1-Benzyl-3-(1,1-dioxido-1,2-benzothiazol-3-yl)-4-hydroxy-5-isopropyl-1,5-dihydro-2H-pyrrol-2-one, is a small molecule identified as a potent and selective inhibitor of IκB kinase β (IKKβ). IKKβ is a crucial enzyme in the classical NF-κB pathway, which plays a significant role in inflammation and cancer. Due to its IKKβ inhibitory activity, it is investigated as a potential anti-inflammatory agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (5s)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2h-pyrrol-2-one.